Results 41 to 50 of about 24,646 (237)

Structure of the lipopeptide antibiotic tsushimycin

open access: yesActa Crystallographica Section D Biological Crystallography, 2005
The amphomycin derivative tsushimycin has been crystallized and its structure determined at 1.0 A resolution. The asymmetric unit contains 12 molecules and with 1300 independent atoms this structure is one of the largest solved using ab initio direct methods.
Bunkoczi, G.   +2 more
openaire   +3 more sources

Molecular mechanism of lipopeptide presentation by CD1a.

open access: yes, 2005
CD1a is expressed on Langerhans cells (LCs) and dendritic cells (DCs), where it mediates T cell recognition of glycolipid and lipopeptide antigens that contain either one or two alkyl chains.
Hu, J   +13 more
core   +2 more sources

Lichenysin Production by Bacillus licheniformis Food Isolates and Toxicity to Human Cells

open access: yesFrontiers in Microbiology, 2022
Bacillus licheniformis can cause foodborne intoxication due to the production of the surfactant lichenysin. The aim of this study was to measure the production of lichenysin by food isolates of B.
Kah Yen Claire Yeak   +7 more
doaj   +1 more source

Resistant Peanut Genotype Reprograms Rhizosphere Metabolism to Enhance Bacterial Wilt Suppression

open access: yesAdvanced Science, EarlyView.
The resistant peanut genotype selectively recruits beneficial bacteria, which coincides with the activation of salicylic acid (SA)‐dependent systemic acquired resistance (SAR) against Ralstonia solanacearum. Keystone rhizosphere metabolites are positively correlated with both beneficial microbiome assembly and SAR gene expression.
Rui Ren   +20 more
wiley   +1 more source

Diversity and functional analysis of LuxR-type transcriptional regulators of cyclic lipopeptide biosynthesis in Pseudomonas fluorescens

open access: yes, 2009
Cyclic lipopeptides (CLPs) are produced by many Pseudomonas species and have several biological functions, including a role in surface motility, biofilm formation, virulence, and antimicrobial activity.
Bruijn, I., de   +2 more
core   +1 more source

Exploitation and engineering of lipopeptide biosynthesis in myxobacteria [PDF]

open access: yes, 2017
To gain a deep understanding of the lipopeptide biosynthesis in myxobacteria, a comprehensive screening of myxobacterial genomes was initially carried out in the course of this thesis leading to the identification and characterization of novel ...
Burgard, Christian
core   +1 more source

Safety, tolerability, and biomarkers of the treatment of mice with aerosolized toll-like receptor ligands

open access: yesFrontiers in Pharmacology, 2014
We have previously discovered a synergistically therapeutic combination of two Toll-like receptor (TLR) ligands, an oligodeoxynucleotide (ODN) and Pam2CSK4.
Victoria eAlfaro   +11 more
doaj   +1 more source

Characterization of the biocontrol activity of three bacterial isolates against the phytopathogen Erwinia amylovora

open access: yesMicrobiologyOpen, 2021
Antibiotics are sprayed on apple and pear orchards to control, among other pathogens, the bacterium Erwinia amylovora, the causative agent of fire blight.
Fadi Dagher   +4 more
doaj   +1 more source

Fungal Antimicrobial Resistance: Mechanisms, Drivers, and Global Clinical Burden

open access: yesChemFoodChem, EarlyView.
ABSTRACT Fungal antimicrobial resistance (AMR) is a growing concern for world health caused by an increase in multidrug‐resistant infections, an increase in environmental reservoirs, and the ineffectiveness of current antifungal treatments. Fungal infections continue to be largely excluded from AMR initiatives while causing over 1.6 million deaths ...
Bikash Baral
wiley   +1 more source

Daptomycin: a novel lipopeptide antibiotic against Gram-positive pathogens

open access: yes, 2010
Andres Beiras-Fernandez1,*, Ferdinand Vogt1,*, Ralf Sodian1, Florian Weis21Department of Cardiac Surgery, University Hospital Großhadern, Ludwig-Maximilian-University, Munich, Germany; 2Department of Anesthesiology, University Hospital Gro& ...
Ferdin   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy